{"celex_id": "32015R0359", "uri": "http://publications.europa.eu/resource/cellar/9a6d9761-c3ce-11e4-bbe1-01aa75ed71a1", "type": "Regulation", "concepts": ["3365", "4258", "5283", "5334", "5899", "5907"], "title": "Commission Regulation (EU) 2015/359 of 4 March 2015 implementing Regulation (EC) No 1338/2008 of the European Parliament and of the Council as regards statistics on healthcare expenditure and financing  Text with EEA relevance\n", "header": "6.3.2015 EN Official Journal of the European Union L 62/6\nCOMMISSION REGULATION (EU) 2015/359\nof 4 March 2015\nimplementing Regulation (EC) No 1338/2008 of the European Parliament and of the Council as regards statistics on healthcare expenditure and financing\n(Text with EEA relevance)\nTHE EUROPEAN COMMISSION", "recitals": ",\nHaving regard to the Treaty on the Functioning of the European Union,\nHaving regard to Regulation (EC) No 1338/2008 of the European Parliament and of the Council of 16 December 2008 on Community statistics on public health and health and safety at work\u00a0(1), and in particular Article 9(1) and Annex II, point (d), thereof,\nWhereas:\n(1) Regulation (EC) No 1338/2008 establishes a common framework for the systematic production of European statistics on public health and health and safety at work.\n(2) Implementing measures determine the data and metadata to be supplied on healthcare expenditure and financing and the reference periods, intervals and time limits for the data provision.\n(3) In accordance with Article 6(2) of Regulation (EC) No 1338/2008, a cost-benefit analysis, taking into account the benefits of the availability of data on healthcare expenditure and financing in relation to the cost of the data collections, which Member States have been conducting on a voluntary basis since 2005 according to the principles set out by the System of Health Accounts, and the burden on Member States, has been carried out. Pursuant to Article 6(1) of Regulation (EC) No 1338/2008, in 2013 and 2014, the Commission instituted pilot studies that were completed on a voluntary basis by the Member States. The Commission has discussed user needs with Member States at various meetings. The availability of EU-wide data is likely to be of great benefit for decisions relating to health and social policy.\n(4) In order to ensure relevance and comparability of data, the System of Health Accounts 2011 manual\u00a0(2), which was produced jointly by the Commission (Eurostat), the Organisation for Economic Cooperation and Development (OECD) and the World Health Organisation (WHO) and sets out the concepts, the definitions and the methods for data processing relating to healthcare expenditure and financing, should form the basis for the detailed questionnaire and the accompanying guidelines used in the joint annual data collection exercise carried out by these three bodies.\n(5) The measures provided for in this Regulation are in accordance with the opinion of the European Statistical System Committee,", "main_body": ["This Regulation lays down rules for the development and production of European statistics in the area of healthcare expenditure and financing, one of the subjects for statistics on healthcare listed in Annex II to Regulation (EC) No\u00a01338/2008.", "The definitions to be used in applying this Regulation are set out in Annex I.", "Member States shall provide data on the areas specified in Annex II.", "1.\u00a0\u00a0\u00a0Member States shall provide the required data and the associated standard reference metadata on an annual basis. The reference period shall be the calendar year.\n2.\u00a0\u00a0\u00a0Data and reference metadata for the reference year N shall be transmitted by 30 April N+2.\n3.\u00a0\u00a0\u00a0Data and reference metadata shall be provided to the Commission (Eurostat) using the single entry point services or should be made available for retrieval by the Commission (Eurostat) by electronic means on an annual basis.\n4.\u00a0\u00a0\u00a0The first reference year shall be 2014.\n5.\u00a0\u00a0\u00a0The last reference year shall be 2020.\n6.\u00a0\u00a0\u00a0By way of derogation from paragraph 2, Member States shall provide the data and reference metadata for the reference year 2014 by 31 May 2016.", "1.\u00a0\u00a0\u00a0Member States shall provide data at the level of aggregation specified in Annex II.\n2.\u00a0\u00a0\u00a0Member States shall provide the necessary reference metadata, in particular concerning the data sources, their coverage and the compilation methods used, information on features of national healthcare expenditure and financing specific to the Member States that deviate from definitions provided in Annex I, references to national legislation where this forms the basis for healthcare expenditure and financing, as well as information on any changes to the statistical concepts mentioned hereto.", "This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 4 March 2015.\nFor the Commission\nThe President\nJean-Claude JUNCKER\n(1)\u00a0\u00a0OJ L\u00a0354, 31.12.2008, p.\u00a070.\n(2)\u00a0\u00a0OECD, Eurostat, WHO (2011), A System of Health Accounts, OECD Publishing, doi: 10.1787/9789264116016-en\nANNEX I\nDefinitions\n1. \u2018Healthcare\u2019 means all activities with the primary purpose of improving, maintaining and preventing the deterioration of the health status of persons and mitigating the consequences of ill-health through the application of qualified health knowledge;\n2. \u2018Current expenditure on healthcare\u2019 means the final consumption expenditure of resident units on healthcare goods and services, including the healthcare goods and services provided directly to individual persons as well as collective healthcare services;\n3. \u2018Healthcare functions\u2019 relate to the type of need that current expenditure on healthcare aims to satisfy or the kind of objective pursued;\n4. \u2018Curative care\u2019 means the healthcare services during which the principal intent is to relieve symptoms or to reduce the severity of an illness or injury, or to protect against its exacerbation or complication that could threaten life or normal function;\n5. \u2018Rehabilitative care\u2019 means the services to stabilise, improve or restore impaired body functions and structures, compensate for the absence or loss of body functions and structures, improve activities and participation and prevent impairments, medical complications and risks;\n6. \u2018Inpatient care\u2019 means the treatment and/or care provided in a healthcare facility to patients formally admitted and requiring an overnight stay;\n7. \u2018Outpatient care\u2019 means the medical and ancillary services delivered in a healthcare facility to a patient who is not formally admitted and does not stay overnight;\n8. \u2018Day care\u2019 means the planned medical and paramedical services delivered in a healthcare facility to patients who have been formally admitted for diagnosis, treatment or other types of healthcare and are discharged on the same day;\n9. \u2018Long-term care (health)\u2019 means a range of medical and personal care services that are consumed with the primary goal of alleviating pain and suffering and reducing or managing the deterioration in health status in patients with a degree of long-term dependency;\n10. \u2018Home-based care\u2019 means the medical, ancillary and nursing services that are consumed by patients at their home and involve the providers' physical presence;\n11. \u2018Ancillary services\u2019 (non-specified by function) means the healthcare or long-term care related services non-specified by function and non-specified by mode of provision, which the patient consumes directly, in particular during an independent contact with the health system and that are not integral part of a care service package, such as laboratory or imaging services or patient transportation and emergency rescue;\n12. \u2018Pharmaceuticals and other medical non-durable goods\u2019 (non-specified by function) means pharmaceutical products and non-durable medical goods intended for use in the diagnosis, cure, mitigation or treatment of disease, including prescribed medicines and over-the-counter drugs, where the function and mode of provision are not specified;\n13. \u2018Therapeutic appliances and other medical goods\u2019 (non-specified by function) means medical durable goods including orthotic devices that support or correct deformities and/or abnormalities of the human body, orthopaedic appliances, prostheses or artificial extensions that replace a missing body part, and other prosthetic devices including implants which replace or supplement the functionality of a missing biological structure and medico-technical devices, where the function and the mode of provision are not specified;\n14. \u2018Preventive care\u2019 means any measure that aims to avoid or reduce the number or the severity of injuries and diseases, their sequelae and complications;\n15. \u2018Governance, and health system and financing administration\u2019 means services that focus on the health system rather than direct healthcare, direct and support health system functioning, and are considered to be collective, as they are not allocated to specific individuals but benefit all health system users;\n16. \u2018Healthcare financing schemes\u2019 means types of financing arrangements through which people obtain health services, including both direct payments by households for services and goods and third-party financing arrangements;\n17. \u2018Government schemes\u2019 means healthcare financing schemes whose characteristics are determined by law or by the government and where a separate budget is set for the programme and a government unit that has an overall responsibility for it;\n18. \u2018Compulsory contributory health insurance scheme\u2019 means a financing arrangement to ensure access to healthcare for specific population groups through mandatory participation determined by law or by the government and eligibility based on the payment of health insurance contributions by or on behalf of the individuals concerned;\n19. \u2018Compulsory medical savings accounts (MSA)\u2019 means savings accounts that are legally compulsory, whereby the basic method for fund-raising and some issues concerning the use of the account to pay for health services are regulated by government, and where there is no pooling across individuals, except for family members;\n20. \u2018Voluntary health insurance schemes\u2019 means schemes based upon the purchase of a health insurance policy, which is not made compulsory by government and where insurance premiums may be directly or indirectly subsidised by the government;\n21. \u2018Non-profit institutions financing schemes\u2019 means non-compulsory financing arrangements and programmes with non-contributory benefit entitlement that are based on donations from the general public, the government or corporations;\n22. \u2018Enterprise financing schemes\u2019 means primarily arrangements where enterprises directly provide or finance health services for their employees without the involvement of an insurance-type scheme;\n23. \u2018Household out-of-pocket payment\u2019 means a direct payment for healthcare goods and services from the household primary income or savings, where the payment is made by the user at the time of the purchase of goods or the use of the services;\n24. \u2018Rest of the world financing schemes\u2019 means financial arrangements involving or managed by institutional units that are resident abroad, but who collect, pool resources and purchase healthcare goods and services on behalf of residents, without transiting their funds through a resident scheme;\n25. \u2018Healthcare providers\u2019 means the organisations and actors that deliver healthcare goods and services as their primary activity, as well as those for which healthcare provision is only one among a number of activities;\n26. \u2018Hospitals\u2019 means the licensed establishments that are primarily engaged in providing medical, diagnostic and treatment services that include physician, nursing and other health services to inpatients and the specialised accommodation services required by inpatients and which may also provide day care, outpatient and home healthcare services;\n27. \u2018Residential long-term care facilities\u2019 means establishments that are primarily engaged in providing residential long-term care that combines nursing, supervisory or other types of care as required by the residents, where a significant part of the production process and the care provided is a mix of health and social services with the health services being largely at the level of nursing care in combination with personal care services;\n28. \u2018Providers of ambulatory healthcare\u2019 means establishments that are primarily engaged in providing healthcare services directly to outpatients who do not require inpatient services, including both offices of general medical practitioners and medical specialists and establishments specialising in the treatment of day-cases and in the delivery of home care services;\n29. \u2018Providers of ancillary services\u2019 means establishments that provide specific ancillary type of services directly to outpatients under the supervision of health professionals and not covered within the episode of treatment by hospitals, nursing care facilities, ambulatory care providers or other providers;\n30. \u2018Retailers and other providers of medical goods\u2019 means establishments whose primary activity is the retail sale of medical goods to the general public for individual or household consumption or utilisation, including fitting and repair done in combination with sale;\n31. \u2018Providers of preventive care\u2019 means organisations that primarily provide collective preventive programmes and campaigns/public health programmes for specific groups of individuals or the population-at-large, such as health promotion and protection agencies or public health institutes as well as specialised establishments providing primary preventive care as their principal activity;\n32. \u2018Providers of healthcare system administration and financing\u2019 means establishments that are primarily engaged in the regulation of the activities of agencies that provide healthcare and in the overall administration of the healthcare sector, including the administration of health financing;\n33. \u2018Rest of the economy\u2019 means other resident healthcare providers not elsewhere classified, including households as providers of personal home health services to family members, in cases where they correspond to social transfer payments granted for this purpose as well as all other industries that offer healthcare as a secondary activity;\n34. \u2018Rest of the world providers\u2019 means all non-resident units providing healthcare goods and services as well as those involved in health-related activities.\nANNEX II\nSubjects to be covered and their characteristics, cross-classification data and breakdowns\n1.\u00a0\u00a0\u00a0Cross-classification current expenditure on healthcare by healthcare functions (HC) and financing schemes (HF)\u00a0(1)\nFinancing schemes HF.1.1 HF.1.2; HF.1.3 HF.2.1 HF.2.2 HF2.3 HF.3 HF.4\nHealthcare functions  Government schemes Compulsory contributory health insurance schemes and Compulsory medical saving accounts\u00a0(2) Voluntary health insurance schemes Non-profit institutions financing schemes Enterprises financing schemes Household out-of-pocket payment Rest of the world financing schemes Current expenditure on healthcare\nHC.1.1; HC.2.1 Inpatient curative and rehabilitative care\nHC.1.2; HC.2.2 Day curative and rehabilitative care\nHC.1.3; HC.2.3 Outpatient curative and rehabilitative care\nHC.1.4; HC.2.4 Home-based curative and rehabilitative care\nHC.3.1 Inpatient long-term care (health)\nHC.3.2 Day long-term care (health)\nHC.3.3 Outpatient long-term care (health)\nHC.3.4 Home-based long-term care (health)\nHC.4 Ancillary services (non-specified by function)\nHC.5.1 Pharmaceuticals and other medical non-durable goods (non-specified by function)\nHC.5.2 Therapeutic appliances and other medical goods (non-specified by function)\nHC.6 Preventive care\u00a0(3)\nHC.7 Governance and health system and financing administration\nHC.9 Other healthcare services not elsewhere classified (n.e.c.)\nCurrent expenditure on healthcare\n2.\u00a0\u00a0\u00a0Cross-classification current expenditure on healthcare by healthcare functions (HC) and healthcare providers (HP)\u00a0(4)\nHealthcare providers HP.1 HP.2 HP.3 HP.4 HP.5 HP.6 HP.7 HP.8 HP.9\nHealthcare functions  Hospitals Residential long-term care facilities Providers of ambulatory healthcare Providers of ancillary services Retailers and other providers of medical goods Providers of preventive care Providers of healthcare system administration and financing Rest of the economy Rest of the world Current expenditure on healthcare\nHC.1.1; HC.2.1 Inpatient curative and rehabilitative care\nHC.1.2; HC.2.2 Day cases of curative and rehabilitative care\nHC.1.3; HC.2.3 Outpatient curative and rehabilitative care\nHC.1.4; HC.2.4 Home-based curative and rehabilitative care\nHC.3.1 Inpatient long-term care (health)\nHC.3.2 Day long-term care (health)\nHC.3.3 Outpatient long-term care (health)\nHC.3.4 Home-based long-term care (health)\nHC.4 Ancillary services (non-specified by function)\nHC.5.1 Pharmaceuticals and other medical non-durable goods (non-specified by function)\nHC.5.2 Therapeutic appliances and other medical goods (non-specified by function)\nHC.6 Preventive care\u00a0(5)\nHC.7 Governance and health system and financing administration\nHC.9 Other healthcare services not elsewhere classified (n.e.c.)\nCurrent expenditure on healthcare\n3.\u00a0\u00a0\u00a0Cross-classification current expenditure on healthcare by healthcare providers (HP) and financing schemes (HF)\u00a0(6)\nFinancing schemes HF.1.1 HF.1.2; HF.1.3 HF.2.1 HF.2.2 HF.2.3 HF.3 HF.4\nHealthcare providers  Government schemes Compulsory contributory health insurance schemes and Compulsory medical saving accounts\u00a0(7) Voluntary health insurance schemes Non-profit institutions financing schemes Enterprises financing schemes Household out-of-pocket payment Rest of the world financing schemes (non-resident) Current expenditure on healthcare\nHP.1 Hospitals\nHP.2 Residential long-term care facilities\nHP.3 Providers of ambulatory healthcare\nHP.4 Providers of ancillary services\nHP.5 Retailers and other providers of medical goods\nHP.6 Providers of preventive care\nHP.7 Providers of healthcare system administration and financing\nHP.8 Rest of the economy\nHP.9 Rest of the world\nCurrent expenditure on healthcare\n(1)\u00a0\u00a0Data shall be transmitted in millions of national currency.\n(2)\u00a0\u00a0Expenditure on HF.1.3 shall be reported in the metadata.\n(3)\u00a0\u00a0Preventive care is based on a health promotion strategy that involves a process to enable people to improve their health through the control over some of its immediate determinants. Interventions are included when their primary purpose is health promotion and if they occur before the diagnosis has been made. Preventive care includes interventions for both individual and collective consumption.\n(4)\u00a0\u00a0Data shall be transmitted in millions of national currency\n(5)\u00a0\u00a0Preventive care is based on a health promotion strategy that involves a process to enable people to improve their health through the control over some of its immediate determinants. Interventions are included when their primary purpose is health promotion and if they occur before the diagnosis has been made. Preventive care includes interventions for both individual and collective consumption.\n(6)\u00a0\u00a0Data shall be transmitted in millions of national currency.\n(7)\u00a0\u00a0Expenditure on HF.1.3 shall be reported in the metadata."}